Abstract Given the inherent complexity of metabolic pathways and disease-associated agents, next-generation healthcare necessitates wearable, non-invasive, and customized approaches to continuously monitor a broad spectrum of physiologically relevant biomarkers for personalized health management. Moreover, existing data-based analytical strategies remain inadequate for delivering quantitative and predictive evaluations of health status in real-life settings. Here, we report an electronic multiplexed microneedle-based biosensor patch (eMPatch) that enables real-time, minimally invasive monitoring of key metabolic biomarkers in interstitial fluid, including glucose, uric acid, cholesterol, sodium, potassium, and pH. By integrating modular microneedle (MN) sensors into a skin-interfaced flexible platform, the eMPatch achieves robust mechanical stability and seamless skin conformity, thereby ensuring reliable and continuous sensing within the dermal space. In vivo validation in animal models under metabolic intervention highlights the strong capability of the eMPatch for real-time physiological tracking across diverse daily activities. Implemented with a machine learning algorithm, the eMPatch enables automatic feature extraction and multi-task health assessment, achieving a classification accuracy of 0.996 in distinguishing normal and diet-induced metabolic disorder for health condition identification and an R 2 score of 0.977 for the corresponding degree evaluation. This study highlights the potential of the MN-integrated, machine learning-enhanced biosensing platform toward personalized health management.
Sun et al. (Mon,) studied this question.